Ongoing projects include (1) characterizing genetic risk factors contributing to clinical outcomes in schizophrenia and related psychotic disorders and (2) exploring differences between clozapine treatment resistance and treatment responsiveness using patient derived brain organoids (done in collaboration with Stein lab https://www.steinlab.org)
Biological approaches to understand psychosis and clinical outcomes
